US Patent Issued to Gilead Sciences on Sept. 8 for "Antibodies that bind to human chemokine (C-C motif) receptor 8 (CCR8)" (Massachusetts, California Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,241, issued on Sept. 8, was assigned to Gilead Sciences Inc. (Foster City, Calif.).

"Antibodies that bind to human chemokine (C-C motif) receptor 8 (CCR8)" was invented by Lara Lewis Mcgrath (Arlington, Mass.), Fabien Depis (Brookline, Mass.), Changyun Hu (Belmont, Mass.), Leonard G. Presta (San Francisco) and Joshua Adam Bugge (Arlington, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are various embodiments relating to antibodies and fusion proteins and uses thereof. Some of the embodiments include antibodies that bind CCR8. Some of the embodiments include fusion proteins that bind CCR8. Such antibodies and fusion proteins ca...